Literature DB >> 25099013

Minireview: hey U(PS): metabolic and proteolytic homeostasis linked via AMPK and the ubiquitin proteasome system.

Sarah M Ronnebaum1, Cam Patterson, Jonathan C Schisler.   

Abstract

One of the master regulators of both glucose and lipid cellular metabolism is 5'-AMP-activated protein kinase (AMPK). As a metabolic pivot that dynamically responds to shifts in nutrient availability and stress, AMPK dysregulation is implicated in the underlying molecular pathology of a variety of diseases, including cardiovascular diseases, diabetes, cancer, neurological diseases, and aging. Although the regulation of AMPK enzymatic activity by upstream kinases is an active area of research, less is known about regulation of AMPK protein stability and activity by components of the ubiquitin-proteasome system (UPS), the cellular machinery responsible for both the recognition and degradation of proteins. Furthermore, there is growing evidence that AMPK regulates overall proteasome activity and individual components of the UPS. This review serves to identify the current understanding of the interplay between AMPK and the UPS and to promote further exploration of the relationship between these regulators of energy use and amino acid availability within the cell.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25099013      PMCID: PMC4179629          DOI: 10.1210/me.2014-1180

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  157 in total

Review 1.  Ubiquitin: same molecule, different degradation pathways.

Authors:  Michael J Clague; Sylvie Urbé
Journal:  Cell       Date:  2010-11-24       Impact factor: 41.582

2.  Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.

Authors:  Matthew S Gentry; Carolyn A Worby; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-01       Impact factor: 11.205

3.  c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action.

Authors:  Juan C Molero; Thomas E Jensen; Phil C Withers; Michelle Couzens; Herbert Herzog; Christine B F Thien; Wallace Y Langdon; Ken Walder; Maria A Murphy; David D L Bowtell; David E James; Gregory J Cooney
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

4.  A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway.

Authors:  Min Xie; Dou Zhang; Jason R B Dyck; Yi Li; Hui Zhang; Masae Morishima; Douglas L Mann; George E Taffet; Antonio Baldini; Dirar S Khoury; Michael D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-03       Impact factor: 11.205

5.  Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside. Evidence for involvement of amp-activated protein kinase.

Authors:  H R Samari; P O Seglen
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

6.  Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.

Authors:  Maria Carmen Solaz-Fuster; José Vicente Gimeno-Alcañiz; Susana Ros; Maria Elena Fernandez-Sanchez; Belen Garcia-Fojeda; Olga Criado Garcia; David Vilchez; Jorge Dominguez; Mar Garcia-Rocha; Maribel Sanchez-Piris; Carmen Aguado; Erwin Knecht; Jose Serratosa; Joan Josep Guinovart; Pascual Sanz; Santiago Rodriguez de Córdoba
Journal:  Hum Mol Genet       Date:  2007-11-20       Impact factor: 6.150

7.  CHIP activates HSF1 and confers protection against apoptosis and cellular stress.

Authors:  Qian Dai; Chunlian Zhang; Yaxu Wu; Holly McDonough; Ryan A Whaley; Virginia Godfrey; Hui-Hua Li; Nageswara Madamanchi; Wanping Xu; Len Neckers; Douglas Cyr; Cam Patterson
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

8.  Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains.

Authors:  Abdallah K Al-Hakim; Anna Zagorska; Louise Chapman; Maria Deak; Mark Peggie; Dario R Alessi
Journal:  Biochem J       Date:  2008-04-15       Impact factor: 3.857

9.  In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I.

Authors:  Shuangxi Wang; Jian Xu; Ping Song; Benoit Viollet; Ming-Hui Zou
Journal:  Diabetes       Date:  2009-06-15       Impact factor: 9.461

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  14 in total

Review 1.  Proteotoxicity and cardiac dysfunction.

Authors:  Patrick M McLendon; Jeffrey Robbins
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

2.  Proteasome Inhibition After Burn Injury.

Authors:  P Geoff Vana; Heather M LaPorte; Yee M Wong; Richard H Kennedy; Richard L Gamelli; Matthias Majetschak
Journal:  J Burn Care Res       Date:  2016 Jul-Aug       Impact factor: 1.845

3.  Delineation of Molecular Pathways Involved in Cardiomyopathies Caused by Troponin T Mutations.

Authors:  Jennifer E Gilda; Xianyin Lai; Frank A Witzmann; Aldrin V Gomes
Journal:  Mol Cell Proteomics       Date:  2016-03-28       Impact factor: 5.911

4.  Impaired Proteasomal Function in Human Osteoarthritic Chondrocytes Can Contribute to Decreased Levels of SOX9 and Aggrecan.

Authors:  Ramon L Serrano; Liang-Yu Chen; Martin K Lotz; Ru Liu-Bryan; Robert Terkeltaub
Journal:  Arthritis Rheumatol       Date:  2018-05-27       Impact factor: 10.995

5.  Non-radiometric Cell-free Assay to Measure the Effect of Molecular Chaperones on AMP-activated Kinase Activity.

Authors:  Elizabeth B Wilson; Carrie E Rubel; Jonathan C Schisler
Journal:  Bio Protoc       Date:  2019-04-20

6.  Bioactive compounds from Artemisia dracunculus L. activate AMPK signaling in skeletal muscle.

Authors:  B Vandanmagsar; Y Yu; C Simmler; T N Dang; P Kuhn; A Poulev; D M Ribnicky; G F Pauli; Z E Floyd
Journal:  Biomed Pharmacother       Date:  2021-09-23       Impact factor: 6.529

7.  CHIP(-/-)-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications.

Authors:  Sung-Mi Kim; James P Grenert; Cam Patterson; Maria Almira Correia
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

8.  AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms.

Authors:  Stavros Kopsiaftis; Poornima Hegde; John A Taylor; Kevin P Claffey
Journal:  Transl Oncol       Date:  2016-12       Impact factor: 4.243

9.  Adverse Effects of Fenofibrate in Mice Deficient in the Protein Quality Control Regulator, CHIP.

Authors:  Saranya Ravi; Traci L Parry; Monte S Willis; Pamela Lockyer; Cam Patterson; James R Bain; Robert D Stevens; Olga R Ilkayeva; Christopher B Newgard; Jonathan C Schisler
Journal:  J Cardiovasc Dev Dis       Date:  2018-08-15

10.  Liraglutide reduces oxidized LDL-induced oxidative stress and fatty degeneration in Raw 264.7 cells involving the AMPK/SREBP1 pathway.

Authors:  Yan-Gui Wang; Tian-Lun Yang
Journal:  J Geriatr Cardiol       Date:  2015-07       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.